Metformin-associated Lactic Acidosis with Hypoglycemia during the COVID-19 Pandemic

Kana Takayama1, Yoshinari Obata1, Yumiko Maruo1

  • 1Department of Diabetes, Metabolism and Endocrinology, Osaka Police Hospital, Japan.

Insights

Metformin-associated lactic acidosis (MALA) is a rare but severe risk of metformin. COVID-19 pandemic lifestyle changes, like increased alcohol intake, may heighten MALA risk in diabetic patients.

Area of Science:

  • Endocrinology
  • Pharmacology
  • Critical Care Medicine

Background:

  • Metformin is a widely prescribed oral hypoglycemic agent for type 2 diabetes.
  • Metformin-associated lactic acidosis (MALA) is a rare but potentially fatal adverse drug reaction.
  • The COVID-19 pandemic introduced lifestyle changes that could impact medication safety.

Observation:

  • A 64-year-old Japanese male patient on a low-dose metformin regimen presented with MALA.
  • The patient also experienced hypoglycemia concurrently with MALA.
  • Increased alcohol consumption, linked to pandemic-related lifestyle shifts, was identified as a trigger.

Findings:

  • This case highlights a rare instance of MALA and hypoglycemia in a patient on low-dose metformin.
  • The patient's increased alcohol intake, a consequence of pandemic lifestyle changes, precipitated the adverse event.
  • This suggests a potential interaction between metformin, alcohol, and pandemic-induced behavioral changes.

Implications:

  • Physicians must exercise caution when prescribing metformin, especially in patients susceptible to lifestyle changes.
  • Close monitoring of patients on metformin is crucial during periods of significant lifestyle alteration, such as pandemics.
  • Awareness of potential triggers like increased alcohol consumption is vital for preventing MALA during the COVID-19 pandemic.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
360
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
315
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
2.0K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
726
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
279